Stockreport

Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]

Longboard Pharmaceuticals, Inc.  (LBPH) 
PDF Recently initiated Phase 3 global clinical trial (the DEEp SEA Study) to evaluate bexicaserin in Dravet syndrome for participants ages 2-65 years LA JOLLA, Calif., No [Read more]